These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8889061)

  • 1. The use of a microporous polyvinylidene fluoride (PVDF) membrane filter to separate contaminating viral particles from biologically important proteins.
    Oshima KH; Evans-Strickfaden TT; Highsmith AK; Ades EW
    Biologicals; 1996 Jun; 24(2):137-45. PubMed ID: 8889061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of filtration properties of hepatitis B virus, hepatitis C virus and simian virus 40 using a polyvinylidene fluoride membrane filter.
    Oshima KH; Evans-Strickfaden T; Highsmith A
    Vox Sang; 1998; 75(3):181-8. PubMed ID: 9852404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The removal of phages T1 and PP7, and poliovirus from fluids with hollow-fiber ultrafilters with molecular weight cut-offs of 50,000, 13,000, and 6000.
    Oshima KH; Evans-Strickfaden TT; Highsmith AK; Ades EW
    Can J Microbiol; 1995; 41(4-5):316-22. PubMed ID: 8590412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus retention by a hydrophilic triple-layer PVDF microporous membrane filter.
    Aranha-Creado H; Oshima K; Jafari S; Howard G; Brandwein H
    PDA J Pharm Sci Technol; 1997; 51(3):119-24. PubMed ID: 9203825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of murine leukaemia virus from monoclonal antibody solution by a hydrophilic PVDF microporous membrane filter.
    Aranha-Creado H; Peterson J; Huang PY
    Biologicals; 1998 Jun; 26(2):167-72. PubMed ID: 9811524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient removal of viruses by a novel polyvinylidene fluoride membrane filter.
    Roberts P
    J Virol Methods; 1997 Apr; 65(1):27-31. PubMed ID: 9128859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.
    Furuya K; Murai K; Yokoyama T; Maeno H; Takeda Y; Murozuka T; Wakisaka A; Tanifuji M; Tomono T
    Vox Sang; 2006 Aug; 91(2):119-25. PubMed ID: 16907872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of LDH activity during membrane filtration.
    Nema S; Avis KE
    J Parenter Sci Technol; 1993; 47(1):16-21. PubMed ID: 8445493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of human immunodeficiency virus by an 0.04-micron membrane filter.
    Oshima KH; Comans TW; Highsmith AK; Ades EW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):64-5. PubMed ID: 8548348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus removal from factor IX by filtration: validation of the integrity test and effect of manufacturing process conditions.
    Roberts PL; Feldman P; Crombie D; Walker C; Lowery K
    Biologicals; 2010 Mar; 38(2):303-10. PubMed ID: 20089418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal virus polarization model for virus retention by the Ultipor(®) VF Grade DV20 membrane.
    Jackson NB; Bakhshayeshi M; Zydney AL; Mehta A; van Reis R; Kuriyel R
    Biotechnol Prog; 2014; 30(4):856-63. PubMed ID: 24616397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb).
    Azari M; Boose JA; Burhop KE; Camacho T; Catarello J; Darling A; Ebeling AA; Estep TN; Pearson L; Guzder S; Herren J; Ogle K; Paine J; Rohn K; Sarajari R; Sun CS; Zhang L
    Biologicals; 2000 Jun; 28(2):81-94. PubMed ID: 10885615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving hydrophilicity and protein resistance of poly(vinylidene fluoride) membranes by blending with amphiphilic hyperbranched-star polymer.
    Zhao YH; Zhu BK; Kong L; Xu YY
    Langmuir; 2007 May; 23(10):5779-86. PubMed ID: 17408299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
    Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
    J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of coliphage PR772 and evaluation of its use for virus filter performance testing.
    Lute S; Aranha H; Tremblay D; Liang D; Ackermann HW; Chu B; Moineau S; Brorson K
    Appl Environ Microbiol; 2004 Aug; 70(8):4864-71. PubMed ID: 15294825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage passage after extended processing in small-virus-retentive filters.
    Lute S; Bailey M; Combs J; Sukumar M; Brorson K
    Biotechnol Appl Biochem; 2007 Jul; 47(Pt 3):141-51. PubMed ID: 17286554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of naked viral genomes in water by virus concentration methods.
    Haramoto E; Katayama H; Oguma K; Ohgaki S
    J Virol Methods; 2007 Jun; 142(1-2):169-73. PubMed ID: 17321606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus disinfection in water by biogenic silver immobilized in polyvinylidene fluoride membranes.
    De Gusseme B; Hennebel T; Christiaens E; Saveyn H; Verbeken K; Fitts JP; Boon N; Verstraete W
    Water Res; 2011 Feb; 45(4):1856-64. PubMed ID: 21183198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a novel Viresolve NFR virus filter.
    Brough H; Antoniou C; Carter J; Jakubik J; Xu Y; Lutz H
    Biotechnol Prog; 2002; 18(4):782-95. PubMed ID: 12153313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.